Related references
Note: Only part of the references are listed.Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer
R. Nedaeinia et al.
CANCER GENE THERAPY (2017)
The Potential for Circulating microRNAs in the Diagnosis of Myocardial Infarction: A Novel Approach to Disease Diagnosis and Treatment
Sharareh Gholamin et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
miR-1303 promotes the proliferation of neuroblastoma cell SH-SY5Y by targeting GSK3β and SFRP1
Zuoqing Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia
S. Fathullahzadeh et al.
CANCER GENE THERAPY (2016)
Circulating microRNA: a new candidate for diagnostic biomarker in neuroblastoma
M. Mohammadi et al.
CANCER GENE THERAPY (2016)
Glioblastoma: exosome and microRNA as novel diagnosis biomarkers
L. Saadatpour et al.
CANCER GENE THERAPY (2016)
Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer Therapies
Reza Salarinia et al.
CURRENT CANCER DRUG TARGETS (2016)
Circulating microRNAs as Potential Diagnostic Biomarkers and Therapeutic Targets in Gastric Cancer: Current Status and Future Perspectives
Hamed Mirzaei et al.
CURRENT MEDICINAL CHEMISTRY (2016)
Circulating microRNAs in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers
Hamid Reza Mirzaei et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma
Hamed Mirzaei et al.
EUROPEAN JOURNAL OF CANCER (2016)
Curcumin: A new candidate for melanoma therapy?
Hamed Mirzaei et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
MicroRNA-451 inhibits neuroblastoma proliferation, invasion and migration by targeting macrophage migration inhibitory factor
Geng Liu et al.
MOLECULAR MEDICINE REPORTS (2016)
MicroRNA-141 and its associated gene FUS modulate proliferation, migration and cisplatin chemosensitivity in neuroblastoma cell lines
Ziran Wang et al.
ONCOLOGY REPORTS (2016)
MicroRNA miR-93-5p regulates expression of IL-8 and VEGF in neuroblastoma SK-N-AS cells
Enrica Fabbri et al.
ONCOLOGY REPORTS (2016)
Role of microRNAs in epigenetic silencing of the CHD5 tumor suppressor gene in neuroblastomas
Koumudi Naraparaju et al.
ONCOTARGET (2016)
microRNA-558 facilitates the expression of hypoxia-inducible factor 2 alpha through binding to 5′-untranslated region in neuroblastoma
Hongxia Qu et al.
ONCOTARGET (2016)
MicroRNA-181a suppresses parkin-mediated mitophagy and sensitizes neuroblastoma cells to mitochondrial uncoupler-induced apoptosis
Min Cheng et al.
ONCOTARGET (2016)
Serum-circulating miRNAs predict neuroblastoma progression in mouse model of high-risk metastatic disease
Satish Kumar Ramraj et al.
ONCOTARGET (2016)
Neuroblastoma: Molecular Pathogenesis and Therapy
Chrystal U. Louis et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma
Anneleen Beckers et al.
CANCER LETTERS (2015)
Disialoganglioside GD2 as a therapeutic target for human diseases
Maya Suzuki et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
miR-362-5p inhibits proliferation and migration of neuroblastoma cells by targeting phosphatidylinositol 3-kinase-C2β
Kai Wu et al.
FEBS LETTERS (2015)
Exosome-Mediated Transfer of microRNAs Within the Tumor Microenvironment and Neuroblastoma Resistance to Chemotherapy
Kishore B. Challagundla et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
MicroRNA-203 inhibits the malignant progression of neuroblastoma by targeting Sam68
Dongju Zhao et al.
MOLECULAR MEDICINE REPORTS (2015)
Targeting MYCN IRES in MYCN-amplified neuroblastoma with miR-375 inhibits tumor growth and sensitizes tumor cells to radiation
Hailong Zhang et al.
MOLECULAR ONCOLOGY (2015)
miRNA-337-3p suppresses neuroblastoma progression by repressing the transcription of matrix metalloproteinase 14
Xuan Xiang et al.
ONCOTARGET (2015)
Genome wide expression profiling of p53 regulated miRNAs in neuroblastoma
Ali Rihani et al.
SCIENTIFIC REPORTS (2015)
Two independent epigenetic biomarkers predict survival in neuroblastoma
Yania Yanez et al.
CLINICAL EPIGENETICS (2015)
Exosome-Mediated Transfer of microRNAs Within the Tumor Microenvironment and Neuroblastoma Resistance to Chemotherapy
Kishore B. Challagundla et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
A Proteomics Approach to Investigate miR-153-3p and miR-205-5p Targets in Neuroblastoma Cells
Ketan S. Patil et al.
PLOS ONE (2015)
miR-200a Inhibits Tumor Proliferation by Targeting AP-2γ in Neuroblastoma Cells
Shun-Li Gao et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
The Risk-Associated Long Noncoding RNA NBAT-1 Controls Neuroblastoma Progression by Regulating Cell Proliferation and Neuronal Differentiation
Gaurav Kumar Pandey et al.
CANCER CELL (2014)
Profiling of circulating miRNAs is a critical prognostic biomarker tool for high-risk neuroblastoma
Satish Kumar Ramraj et al.
CANCER RESEARCH (2014)
Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy
Mahiuddin Ahmed et al.
FEBS LETTERS (2014)
Deep MicroRNA Sequencing Reveals Downregulation of miR-29a in Neuroblastoma Central Nervous System Metastasis
Irene Y. Cheung et al.
GENES CHROMOSOMES & CANCER (2014)
Recent insights into the biology of neuroblastoma
Gudrun Schleiermacher et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Biomarker Modulations in Children With Neuroblastoma Following Treatment With 131I-mIBG
B. S. Imber et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Identification of plasma Complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach
Patrick Y. Kim et al.
JOURNAL OF PROTEOMICS (2014)
microRNA-202 suppresses MYCN expression under the control of E2F1 in the neuroblastoma cell line LAN-5
Yu-Guang Li et al.
MOLECULAR MEDICINE REPORTS (2014)
Mechanisms of neuroblastoma regression
Garrett M. Brodeur et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Chimeric Antibody c. 8B6 to O-Acetyl-GD2 Mediates the Same Efficient Anti-Neuroblastoma Effects as Therapeutic ch14.18 Antibody to GD2 without Antibody Induced Allodynia
Mickael Terme et al.
PLOS ONE (2014)
GD2-Targeted Immunotherapy and Radioimmunotherapy
Konstantin Dobrenkov et al.
SEMINARS IN ONCOLOGY (2014)
MicroRNA-23a promotes neuroblastoma cell metastasis by targeting CDH1
Lin Cheng et al.
ONCOLOGY LETTERS (2014)
B3GNT3 expression suppresses cell migration and invasion and predicts favorable outcomes in neuroblastoma
Wan-Ling Ho et al.
CANCER SCIENCE (2013)
Identification of novel biomarkers in neuroblastoma associated with the risk for bone marrow metastasis: a pilot study
J. Osman et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2013)
β-1,4-Galactosyltransferase III Enhances Invasive Phenotypes Via β1-Integrin and Predicts Poor Prognosis in Neuroblastoma
Hsiu-Hao Chang et al.
CLINICAL CANCER RESEARCH (2013)
GALNT9 Gene Expression Is a Prognostic Marker in Neuroblastoma Patients
Nora Berois et al.
CLINICAL CHEMISTRY (2013)
Multidrug Resistance and Cancer Stem Cells in Neuroblastoma and Hepatoblastoma
Anna Alisi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Epithelial-mesenchymal transition-related gene expression as a new prognostic marker for neuroblastoma
Megumi Nozato et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1
Laura Creevey et al.
MOLECULAR CANCER (2013)
MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma
Marco Lodrini et al.
NUCLEIC ACIDS RESEARCH (2013)
Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs
S. Das et al.
ONCOGENE (2013)
Minimal residual disease monitoring in neuroblastoma patients based on the expression of a set of real-time RT-PCR markers in tumor-initiating cells
Tri Budi Hartomo et al.
ONCOLOGY REPORTS (2013)
Study of the mechanisms underlying the reversal of multidrug resistance of human neuroblastoma multidrug-resistant cell line SK-N-SH/MDR1 by low-intensity pulsed ultrasound
Yanhui Sun et al.
ONCOLOGY REPORTS (2013)
Proteome Profiling of Neuroblastoma-Derived Exosomes Reveal the Expression of Proteins Potentially Involved in Tumor Progression
Danilo Marimpietri et al.
PLOS ONE (2013)
miR-335 and miR-363 regulation of neuroblastoma tumorigenesis and metastasis
Jingbo Qiao et al.
SURGERY (2013)
MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome
J. Ryan et al.
BRITISH JOURNAL OF CANCER (2012)
MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway
Jennifer Lynch et al.
CARCINOGENESIS (2012)
Promising Therapeutic Targets in Neuroblastoma
Katherine K. Matthay et al.
CLINICAL CANCER RESEARCH (2012)
Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review)
Alessandro Allegra et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment
Nidale Tarek et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-Cis-Retinoic Acid in High-Risk Patients With Stage 4 Neuroblastoma in First Remission
Nai-Kong V. Cheung et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Circulating microRNAs in cancer: origin, function and application
Ruimin Ma et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
N-myc and Noncoding RNAs in Neuroblastoma
Jochen Buechner et al.
MOLECULAR CANCER RESEARCH (2012)
microRNA-9 Targets Matrix Metalloproteinase 14 to Inhibit Invasion, Metastasis, and Angiogenesis of Neuroblastoma Cells
Huanyu Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2012)
A New Module in Neural Differentiation Control: Two MicroRNAs Upregulated by Retinoic Acid, miR-9 and-103, Target the Differentiation Inhibitor ID2
Daniela Annibali et al.
PLOS ONE (2012)
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers
Anneleen Decock et al.
GENOME BIOLOGY (2012)
Humanizing murine IgG3 anti-GD2 antibody m3F8 substantially improves antibody-dependent cell-mediated cytotoxicity while retaining targeting in vivo
Nai-Kong V. Cheung et al.
ONCOIMMUNOLOGY (2012)
B4GALNT3 Expression Predicts a Favorable Prognosis and Suppresses Cell Migration and Invasion via β1 Integrin Signaling in Neuroblastoma
Wen-Ming Hsu et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma
Helena Caren et al.
BMC CANCER (2011)
MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma
Amanda Tivnan et al.
BMC CANCER (2011)
Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma
J. Buechner et al.
BRITISH JOURNAL OF CANCER (2011)
Retinoic Acid Induces REST Degradation and Neuronal Differentiation by Modulating the Expression of SCFβ-TRCP in Neuroblastoma Cells
Akanksha Singh et al.
CANCER (2011)
Successful Multifold Dose Escalation of Anti-GD2 Monoclonal Antibody 3F8 in Patients With Neuroblastoma: A Phase I Study
Brian H. Kushner et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Identification of Phosphoproteins as Possible Differentiation Markers in All-Trans-Retinoic Acid-Treated Neuroblastoma Cells
Giorgia Mandili et al.
PLOS ONE (2011)
A Monoclonal Antibody to O-Acetyl-GD2 Ganglioside and Not to GD2 Shows Potent Anti-Tumor Activity without Peripheral Nervous System Cross-Reactivity
Nidia Alvarez-Rueda et al.
PLOS ONE (2011)
ANTI-GD2 STRATEGY IN THE TREATMENT OF NEUROBLASTOMA
R. K. Yang et al.
DRUGS OF THE FUTURE (2010)
Urine catecholamine levels as diagnostic markers for neuroblastoma in a defined population: implications for ophthalmic practice
S. J. Smith et al.
EYE (2010)
MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2
Niamh H. Foley et al.
MOLECULAR CANCER (2010)
The miR-17-92 MicroRNA Cluster Regulates Multiple Components of the TGF-β Pathway in Neuroblastoma
Pieter Mestdagh et al.
MOLECULAR CELL (2010)
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma.
Alice L. Yu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Medical Progress: Recent Advances in Neuroblastoma.
John M. Maris
NEW ENGLAND JOURNAL OF MEDICINE (2010)
KIR and HLA Genotypes Are Associated with Disease Progression and Survival following Autologous Hematopoietic Stem Cell Transplantation for High-Risk Neuroblastoma
Jeffrey M. Venstrom et al.
CLINICAL CANCER RESEARCH (2009)
MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness
Cristina Evangelisti et al.
FASEB JOURNAL (2009)
Widespread Dysregulation of MiRNAs by MYCN Amplification and Chromosomal Imbalances in Neuroblastoma: Association of miRNA Expression with Survival
Isabella Bray et al.
PLOS ONE (2009)
Exploiting Gene Expression Profiling to Identify Novel Minimal Residual Disease Markers of Neuroblastoma
Irene Y. Cheung et al.
CLINICAL CANCER RESEARCH (2008)
Identification of GRP75 as an Independent Favorable Prognostic Marker of Neuroblastoma by a Proteomics Analysis
Wen-Ming Hsu et al.
CLINICAL CANCER RESEARCH (2008)
mRNAs of tyrosine hydroxylase and dopa decarboxylase but not of GD2 synthase are specific for neuroblastoma minimal disease and predicts outcome for children with high-risk disease when measured at diagnosis
Catarina Trager et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
BIOCHEMICAL PARAMETERS IN NEUROBLASTOMA
S. T. Bolkar et al.
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY (2008)
Serum protein profiling to identify high-risk neuroblastoma: Preclinical relevance of blood-based biomarkers
John A. Sandoval et al.
JOURNAL OF SURGICAL RESEARCH (2007)
The interplay between microRNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblastoma cells
Pietro Laneve et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis
Yongxin Chen et al.
CANCER RESEARCH (2007)
Tissue microenvironment modulates CXCR4 expression and tumor metastasis in neuroblastoma
Libo Zhang et al.
NEOPLASIA (2007)
ppGalNAc-T13:: A new molecular marker of bone marrow involvement in neuroblastoma
Nora Berois et al.
CLINICAL CHEMISTRY (2006)
Sialyltransferase STX (ST8SiaII): A novel molecular marker of metastatic neuroblastoma
IY Cheung et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Mechanisms and strategies to overcome multiple drug resistance in cancer
Tomris Ozben
FEBS LETTERS (2006)
Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1α in neuroblastoma cells
K Nakamura et al.
CANCER RESEARCH (2006)
High expression of N-acetylglucosaminyltransferase V in favorable neuroblastomas:: Involvement of its effect on apoptosis
K Inamori et al.
FEBS LETTERS (2006)
Protein chip array profiling analysis of sera from neuroblastoma patients
V Combaret et al.
CANCER LETTERS (2005)
Multiple drug resistance in cancer revisited: The cancer stem cell hypothesis
VS Donnenberg et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
The doublecortin gene, a new molecular marker to detect minimal residual disease in neuroblastoma
S Oltra et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2005)
GRP78 expression correlates with histologic differentiation and favorable prognosis in neuroblastic tumors
WM Hsu et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Mass Spectrometry as a diagnostic and a cancer biomarker discovery tool - Opportunities and potential limitations
EP Diamandis
MOLECULAR & CELLULAR PROTEOMICS (2004)
MYCN-mediated regulation of the MRP1 promoter in human neuroblastoma
CF Manohar et al.
ONCOGENE (2004)
Quantitative analysis of tyrosine hydroxylase mRNA for sensitive detection of neuroblastorna cells in blood and bone marrow
C Trager et al.
CLINICAL CHEMISTRY (2003)
Phase II trial of the anti-GD2 monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma
BH Kushner et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Phase I study of chimeric human/murine anti-ganglioside GD2 monoclonal antibody (ch14.18) with granulocyte-macrophage colony-stimulating factor in children with neuroblastoma immediately after hematopoietic stem-cell transplantation:: A Children's Cancer Group Study
MF Ozkaynak et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
